drugset / Trial / NCT04039516
Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy
Phase 2
Unknown
20 enrolled
King's College Hospital NHS Trust
Advanced Accelerator Applications · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Randomised trial to assess progression of carcinoid heart disease in patients treated with Lutathera therapy compared to best supportive care.
Timeline
- Start
- 2020-10
- Primary completion
- 2024-11
- Completion
- 2024-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 177Lu-DOTATATE | Peptide | 7400 mbq | — |